Balyasny Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.64M | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $7.1M | Sell |
|
|||||
|
2024
Q4 | $23.7M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $7.67M | Sell |
|
|||||
|
2024
Q1 | $13.7M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $27.7M | Sell |
|
|||||
|
2023
Q1 | $40.8M | Buy |
|
|||||
|
2022
Q4 | $13.3M | Buy |
|
|||||
|
2022
Q3 | $3.23M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $6.08M | Sell |
|
|||||
|
2021
Q3 | $6.04M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $1.07M | Sell |
|
|||||
|
2018
Q2 | $1.44M | Buy |
|